NDC 51662-1409-2 - HEPARIN SODIUM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1409
- Requested NDC
- 51662-1409-2
- Package NDCs from labels
- 51662-1409-1, 51662-1409-2, 51662-1409-3
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2024-01-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HEPARIN SODIUM - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1409-1 | HEPARIN SODIUM | 5 mL in 1 VIAL | INJECTION, SOLUTION | 5 | 5 | |
| 51662-1409-2 | HEPARIN SODIUM | 1 in 1 POUCH | INJECTION, SOLUTION | 1 | 5 | |
| 51662-1409-2 | HEPARIN SODIUM | 5 mL in 1 VIAL | INJECTION, SOLUTION | 5 | 5 | |
| 51662-1409-3 | HEPARIN SODIUM | 25 in 1 CASE | INJECTION, SOLUTION | 25 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1409 | HEPARIN SODIUM INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 5 | Current NDC, Legacy NDC, 4 package rows | 20240131_971505d4-f78c-6f5d-e053-2995a90a00e0.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Heparin Sodium | HEPARIN SODIUM | REMEDYREPACK INC. | a5fab0b1-c472-489c-ba87-2f8e53356173 | 2026-01-16 | Warnings, Adverse reactions | ZZ45AB24CA |
| Endotoxin Terrain Drops 2143 | ENDOTOXIN TERRAIN DROPS | Professional Complementary Health Formulas | 58842566-005a-48b5-973d-20cde2fbd701 | 2026-01-08 | Warnings | QTT17582CB |
| Abdominal Pain Drops 2051 | ABDOMINAL PAIN DROPS | Professional Complementary Health Formulas | f1b1dde6-bb37-4774-a58c-b4f648f9c2b5 | 2026-01-08 | Warnings | QTT17582CB |
| Heparin Sodium | HEPARIN SODIUM | Medical Purchasing Solutions, LLC | 463e0624-b8c3-386b-e063-6294a90afd28 | 2025-12-18 | Warnings, Adverse reactions | 1361226 ZZ45AB24CA |
| Hemorrhoid | AESCULUS HIPP, HAMAMELIS, ALOE, CALC PHOS, CARBO AN, CARBO VEG, LACHESIS, LYCOPODIUM, MURIATICUM AC, NITRICUM AC, NUX VOM, PAEONIA, RATANHIA, SEPIA, SULPHUR | Natural Creations, Inc | db1b3aef-ba92-417c-b6f6-58e950ed4214 | 2025-12-16 | Warnings | QTT17582CB |
| Heparin Sodium | HEPARIN SODIUM | Fresenius Kabi USA, LLC | d55b4a63-0c04-4874-b74f-9e9b9e8b008c | 2025-11-28 | Warnings, Adverse reactions | NDA017029 63323-542 1361226 1658634 1362831 1361615 1361574 1658647 529104c9-6154-4428-953d-5546875f32e5 d55b4a63-0c04-4874-b74f-9e9b9e8b008c ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Fresenius Kabi USA, LLC | ed937dd2-8fab-4875-a1e8-627b71ccb7fb | 2025-11-27 | Warnings, Adverse reactions | NDA017029 1361226 1361615 ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Sagent Pharmaceticals | ef309d83-7262-4874-8580-f4ca254f963a | 2025-11-18 | Warnings, Adverse reactions | 1361226 1362831 1361615 ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Sagent Pharmaceuticals | 6d5eae7d-a5f6-411c-b589-3e5f7eecc875 | 2025-11-18 | Warnings, Adverse reactions | 1658647 ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Sagent Pharmaceuticals | feec2820-502f-4a97-84c9-f173729c51d3 | 2025-11-18 | Warnings, Adverse reactions | 1361574 ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Sagent Pharmaceuticals | 8ebe4b4d-cb28-47e8-9598-6105d250b3d2 | 2025-11-18 | Warnings, Adverse reactions | 1361226 1362831 1361615 ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Henry Schein, Inc. | 3a998729-c912-4e21-8e49-d1e72ba6fe9e | 2025-10-31 | Warnings, Adverse reactions | NDA017029 1361226 ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Pfizer Laboratories Div Pfizer Inc | 56dc3074-f1c5-45a3-b923-f1d14858e06d | 2025-10-03 | Warnings, Adverse reactions | 1361226 1362831 1361615 1658647 ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Meitheal Pharmaceuticals Inc. | 02fb700d-a28c-4d45-b78d-382dc0d5986c | 2025-09-26 | Warnings, Adverse reactions | 1361226 1362831 1361615 ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Medical Purchasing Solutions, LLC | 3edf9198-b88d-7808-e063-6394a90ae89c | 2025-09-15 | Warnings, Adverse reactions | 1361226 ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Medical Purchasing Solutions, LLC. | 3ea2bd53-ed13-a516-e063-6394a90a5dd9 | 2025-09-12 | Warnings, Adverse reactions | 1361226 ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Fresenius Kabi USA, LLC | 9207cef5-4cec-41e7-a351-29ba726feb44 | 2025-08-15 | Warnings, Adverse reactions | NDA017029 ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Fresenius Kabi USA, LLC | 07438e10-1589-4683-9f26-e5494d076cf0 | 2025-08-15 | Warnings, Adverse reactions | ZZ45AB24CA |
| Heparin Sodium | HEPARIN SODIUM | Hikma Pharmaceuticals USA Inc. | 7014808d-cec9-4b2c-8eb5-940493e356ab | 2025-08-13 | Warnings, Adverse reactions | 1361226 1362831 1361615 ZZ45AB24CA |
| Heparin Sodium in Sodium Chloride | HEPARIN SODIUM IN SODIUM CHLORIDE | B. Braun Medical Inc. | a3041c04-0ea8-4d36-81ce-c5091c906316 | 2025-08-06 | Warnings, Adverse reactions | ZZ45AB24CA |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.